Financials
Income statement
Fiscal date | Mar 2024 | Dec 2017 | Sep 2017 | Dec 2016 |
---|---|---|---|---|
Total reported revenue | — | — | — | — |
Cost of revenue | — | — | — | — |
Gross profit | — | 11.2B | 10.5B | 8.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 8.7B | 3.6B | 7.2B |
Other operating expenses | — | — | — | — |
Operating income | — | 5.4B | 5.0B | 1.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 2.6B | 2.6B | 3.1B |
Other income expense | — | — | — | — |
Pretax income | — | 4.0B | 2.9B | 2.4B |
Tax provision | — | 1.6B | 791.7M | 699.0M |
Net income | — | 2.4B | 2.1B | 1.7B |
Basic EPS | -0.2 | — | — | — |
Diluted EPS | -0.2 | — | — | — |
Basic average shares | 1.0B | — | — | — |
Diluted average shares | 1.0B | — | — | — |
EBITDA | — | 6.8B | 5.1B | 5.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -903.6M | -918.0M | -794.2M |
Preferred stock dividends | — | 652.5M | 0 | 0 |